Beckman Coulter Reports Strong Q1 Sales for Dx, Life Science Products

The firm reported particularly strong growth for its clinical diagnostics segment, which posted 30 percent revenue growth.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.